Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK3 | P52333 | 1/20 | 0.51 |
| ▸ | MAPK3 | P27361 | 13/20 | 0.48 |
| ▸ | SYK | P43405 | 1/20 | 0.42 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.42 |
| ▸ | EGFR | P00533 | 1/20 | 0.42 |
| ▸ | FGFR4 | P22455 | 2/20 | 0.42 |
| ▸ | TTK | P33981 | 1/20 | 0.42 |
| ▸ | RPS6KB2 | Q9UBS0 | 1/20 | 0.42 |
| ▸ | PLK1 | P53350 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21600965 | 0.89 | JAK3 (0.60) | JAK3MAPK3SYKMAP3K7EGFR | |
| SCHEMBL21600959 | 0.87 | JAK3 (0.58) | JAK3MAPK3MAP3K7EGFRFGFR4 | |
| SCHEMBL21600914 | 0.87 | JAK3 (0.54) | JAK3MAPK3MAP3K7EGFR | |
| SCHEMBL21596347 | 0.86 | PLK1 (0.56) | JAK3MAPK3EGFRFGFR4PLK1 | |
| SCHEMBL30379344 | 0.85 | MAPK3 (0.54) | JAK3MAPK3EGFRFGFR4 | |
| SCHEMBL21600916 | 0.85 | JAK3 (0.49) | JAK3MAPK3EGFRFGFR4TTK | |
| SCHEMBL21600758 | 0.85 | MAPK3 (0.54) | JAK3MAPK3EGFRFGFR4 | |
| SCHEMBL21600919 | 0.84 | JAK3 (0.49) | JAK3MAPK3EGFRFGFR4 | |
| SCHEMBL21600888 | 0.84 | JAK3 (0.51) | JAK3MAPK3MAP3K7EGFRFGFR4 | |
| SCHEMBL21600889 | 0.84 | JAK3 (0.51) | JAK3MAPK3EGFRFGFR4TTK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019242689-A1 | CYANO-SUBSTITUTED PYRIDINE AND CYANO-SUBSTITUTED PYRIMIDINE COMPOUND, AND PREPARATION METHOD AND APPLICATION THEREOF | 北京赛特明强医药科技有限公司 | 2019-12-26 | — | — | WO | disclosed |